bucladesine has been researched along with oxypurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Flavahan, NA; Horibe, M; Murray, PA; Smedira, NG; Yoshida, K | 1 |
2 other study(ies) available for bucladesine and oxypurinol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation.
Topics: Adrenergic beta-Agonists; Animals; Bucladesine; Cholera Toxin; Colforsin; Cyclic AMP; Cyclic GMP; Dogs; Endothelium, Vascular; Isoproterenol; Lung Transplantation; Oxypurinol; Pulmonary Artery; Transplantation, Autologous; Vasodilation | 1999 |